Atherosclerosis in the apolipoprotein-E-deficient mouse: a decade of progress
- PMID: 15087308
- DOI: 10.1161/01.ATV.0000128849.12617.f4
Atherosclerosis in the apolipoprotein-E-deficient mouse: a decade of progress
Abstract
Arguably the most critical advancement in the elucidation of factors affecting atherogenesis has been the development of mouse models of atherosclerosis. Among available models, the apolipoprotein E-deficient (apoE-/-) mouse is particularly popular because of its propensity to spontaneously develop atherosclerotic lesions on a standard chow diet. A Medline search reveals over 645 articles dedicated to studies using this reliable and convenient "super" animal model since its inception (Piedrahita JA et al, Proc Natl Acad Sci U S A 1992;89:4471-4475; Plump AS et al, Cell 1992;71:343-353) with a more or less steady increase from year to year. This review will examine our present understanding of the pathology and progression of plaques in this animal and highlight some of the nutritional, pharmacological, and genetic studies that have enhanced this understanding.
Similar articles
-
Apolipoprotein E and atherosclerosis: beyond lipid effect.Arterioscler Thromb Vasc Biol. 2005 Feb;25(2):267-9. doi: 10.1161/01.ATV.0000154570.50696.2c. Arterioscler Thromb Vasc Biol. 2005. PMID: 15681305 No abstract available.
-
Apolipoprotein E promotes the regression of atherosclerosis independently of lowering plasma cholesterol levels.Arterioscler Thromb Vasc Biol. 2005 Feb;25(2):436-41. doi: 10.1161/01.ATV.0000152613.83243.12. Epub 2004 Dec 9. Arterioscler Thromb Vasc Biol. 2005. PMID: 15591220
-
Plaque rupture after short periods of fat feeding in the apolipoprotein E-knockout mouse: model characterization and effects of pravastatin treatment.Circulation. 2005 Mar 22;111(11):1422-30. doi: 10.1161/01.CIR.0000158435.98035.8D. Circulation. 2005. PMID: 15781753
-
Mouse models of experimental atherosclerosis.J Physiol Pharmacol. 2004 Sep;55(3):503-17. J Physiol Pharmacol. 2004. PMID: 15381823 Review.
-
A mouse model for human atherosclerosis: long-term histopathological study of lesion development in the aortic arch of apolipoprotein E-deficient (E0) mice.Acta Histochem. 2006;108(6):415-24. doi: 10.1016/j.acthis.2006.07.002. Epub 2006 Sep 26. Acta Histochem. 2006. PMID: 17007910 Review.
Cited by
-
Sex Difference in Coronary Endothelial Dysfunction in Apolipoprotein E Knockout Mouse: Role of NO and A2A Adenosine Receptor.Microcirculation. 2015 Oct;22(7):518-27. doi: 10.1111/micc.12222. Microcirculation. 2015. PMID: 26201383 Free PMC article.
-
Subsurface ablation of atherosclerotic plaque using ultrafast laser pulses.Biomed Opt Express. 2015 Jun 16;6(7):2552-61. doi: 10.1364/BOE.6.002552. eCollection 2015 Jul 1. Biomed Opt Express. 2015. PMID: 26203381 Free PMC article.
-
Semi-quantitative elemental imaging of corrosion products from bioabsorbable Mg vascular implants in vivo.Bioact Mater. 2024 Sep 24;43:225-239. doi: 10.1016/j.bioactmat.2024.07.023. eCollection 2025 Jan. Bioact Mater. 2024. PMID: 39386222 Free PMC article.
-
Dietary ellagic acid blocks inflammation-associated atherosclerotic plaque formation in cholesterol-fed apoE-deficient mice.Nutr Res Pract. 2024 Oct;18(5):617-632. doi: 10.4162/nrp.2024.18.5.617. Epub 2024 Jul 10. Nutr Res Pract. 2024. PMID: 39398881 Free PMC article.
-
Enalapril reverses high-fat diet-induced alterations in cytochrome P450-mediated eicosanoid metabolism.Am J Physiol Endocrinol Metab. 2012 Mar 1;302(5):E500-9. doi: 10.1152/ajpendo.00370.2011. Epub 2011 Dec 20. Am J Physiol Endocrinol Metab. 2012. PMID: 22185841 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
